<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta name="generator" content="MediaWiki 1.13.3" />
		<meta name="keywords" content="Pseudoephedrine,Pseudoephedrine.png,Nasal preparations,Cite book/editor,ATC code R01,Acetaminophen,Acid anhydride,Actifed,Acyl chloride,Adrenergic receptor,Agonist" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/opensearch_desc.php" title="wikidoc (en)" />
		<link title="Creative Commons" type="application/rdf+xml" href="/index.php?title=Pseudoephedrine&amp;action=creativecommons" rel="meta" />
		<link rel="copyright" href="http://creativecommons.org/licenses/by-sa/3.0/" />
		<link rel="alternate" type="application/rss+xml" title="wikidoc RSS Feed" href="http://www.wikidoc.org/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="wikidoc Atom Feed" href="http://www.wikidoc.org/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Pseudoephedrine - wikidoc</title>
		<style type="text/css" media="screen, projection">/*<![CDATA[*/
			@import "/skins/common/shared.css?164";
			@import "/skins/monobook/main.css?164";
		/*]]>*/</style>
		<link rel="stylesheet" type="text/css" media="print" href="/skins/common/commonPrint.css?164" />
		<!--[if lt IE 5.5000]><style type="text/css">@import "/skins/monobook/IE50Fixes.css?164";</style><![endif]-->
		<!--[if IE 5.5000]><style type="text/css">@import "/skins/monobook/IE55Fixes.css?164";</style><![endif]-->
		<!--[if IE 6]><style type="text/css">@import "/skins/monobook/IE60Fixes.css?164";</style><![endif]-->
		<!--[if IE 7]><style type="text/css">@import "/skins/monobook/IE70Fixes.css?164";</style><![endif]-->
		<!--[if lt IE 7]><script type="text/javascript" src="/skins/common/IEFixes.js?164"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->
		
		<script type= "text/javascript">/*<![CDATA[*/
var skin = "monobook";
var stylepath = "/skins";
var wgArticlePath = "/index.php/$1";
var wgScriptPath = "";
var wgScript = "/index.php";
var wgVariantArticlePath = false;
var wgActionPaths = [];
var wgServer = "http://www.wikidoc.org";
var wgCanonicalNamespace = "";
var wgCanonicalSpecialPageName = false;
var wgNamespaceNumber = 0;
var wgPageName = "Pseudoephedrine";
var wgTitle = "Pseudoephedrine";
var wgAction = "view";
var wgArticleId = "8588";
var wgIsArticle = true;
var wgUserName = null;
var wgUserGroups = null;
var wgUserLanguage = "en";
var wgContentLanguage = "en";
var wgBreakFrames = false;
var wgCurRevisionId = "470181";
var wgVersion = "1.13.3";
var wgEnableAPI = true;
var wgEnableWriteAPI = false;
var wgMWSuggestTemplate = "http://www.wikidoc.org/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}";
var wgDBname = "wikidb";
var wgSearchNamespaces = [0, 100];
var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
var wgRestrictionEdit = [];
var wgRestrictionMove = [];
/*]]>*/</script>
                
		<script type="text/javascript" src="/skins/common/wikibits.js?164"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<link rel="stylesheet" type="text/css" href="/extensions/ContributorsAddon/ContributorsAddon.css" />		<script type="text/javascript" src="/extensions/ContributorsAddon/ContributorsAddon.js"><!-- ContributorsAddon js --></script>		
<script type="text/javascript">
var contributorsText = "<h2>Main contributors to <a href=\"/index.php/Pseudoephedrine\" title=\"Pseudoephedrine\">Pseudoephedrine</a></h2><ul><li><a href=\"/index.php/User:Zorkun\" title=\"User:Zorkun\">Zorkun</a> (<a href=\"/index.php/User_talk:Zorkun\" title=\"User talk:Zorkun\">Talk</a> | <a href=\"/index.php/Special:Contributions/Zorkun\" title=\"Special:Contributions/Zorkun\">contribs</a>) [4]</li><li><a href=\"/index.php?title=User:Pilar_Almonacid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Pilar Almonacid (not yet written)\">Pilar Almonacid</a> (<a href=\"/index.php?title=User_talk:Pilar_Almonacid&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User talk:Pilar Almonacid (not yet written)\">Talk</a> | <a href=\"/index.php/Special:Contributions/Pilar_Almonacid\" title=\"Special:Contributions/Pilar Almonacid\">contribs</a>) [3]</li><li><a href=\"/index.php/User:Alara\" title=\"User:Alara\">Alara</a> (<a href=\"/index.php/User_talk:Alara\" title=\"User talk:Alara\">Talk</a> | <a href=\"/index.php/Special:Contributions/Alara\" title=\"Special:Contributions/Alara\">contribs</a>) [2]</li><li><a href=\"/index.php?title=User:Alexandra_Almonacid_E.&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User:Alexandra Almonacid E. (not yet written)\">Alexandra Almonacid E.</a> (<a href=\"/index.php?title=User_talk:Alexandra_Almonacid_E.&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User talk:Alexandra Almonacid E. (not yet written)\">Talk</a> | <a href=\"/index.php/Special:Contributions/Alexandra_Almonacid_E.\" title=\"Special:Contributions/Alexandra Almonacid E.\">contribs</a>) [2]</li><li><a href=\"/index.php/Special:Contributions/63.226.203.246\" title=\"Special:Contributions/63.226.203.246\">63.226.203.246</a> (<a href=\"/index.php?title=User_talk:63.226.203.246&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User talk:63.226.203.246 (not yet written)\">Talk</a>) [1]</li><li><a href=\"/index.php/Special:Contributions/SmackBot\" title=\"Special:Contributions/SmackBot\">SmackBot</a> (<a href=\"/index.php?title=User_talk:SmackBot&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"User talk:SmackBot (not yet written)\">Talk</a>) [1]</li></ul>";
</script>
		<script type="text/javascript" src="/skins/common/ajax.js?164"></script>
		<script type="text/javascript" src="/extensions/AjaxShowEditors/AjaxShowEditors.js"></script>
		<script type="text/javascript" src="/skins/common/mwsuggest.js?164"></script>
		<script type="text/javascript" src="/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
		<style type="text/css">/*<![CDATA[*/
@import "/index.php?title=MediaWiki:Common.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=18000";
@import "/index.php?title=MediaWiki:Monobook.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=18000";
@import "/index.php?title=-&action=raw&gen=css&maxage=18000&useskin=monobook";
/*]]>*/</style>
	</head>
<body class="mediawiki ns-0 ltr page-Pseudoephedrine">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
				<h1 class="firstHeading">Pseudoephedrine</h1>
		<div id="bodyContent">
			<h3 id="siteSub">You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">


<tr>
<td align="center" colspan="2"> <a href="/index.php/Image:Pseudoephedrine_structure.svg" class="image" title="175pxpx }}"><img alt="175pxpx }}" src="/images/thumb/5/54/Pseudoephedrine_structure.svg/175px-Pseudoephedrine_structure.svg" width="175" height="98" border="0" /></a>
</td></tr>
<tr>
<td align="center" colspan="2"> <a href="/index.php/Image:Pseudoephedrine-3d-CPK.png" class="image" title="175pxpx }}"><img alt="175pxpx }}" src="/images/thumb/1/17/Pseudoephedrine-3d-CPK.png/175px-Pseudoephedrine-3d-CPK.png" width="175" height="122" border="0" /></a>
</td></tr>
<tr>
<td align="center" colspan="2"> <div style="font-size:medium; line-height:167%;"> Pseudoephedrine
</div>
</td></tr>
<tr>
<td align="center" colspan="2" bgcolor="#dddddd"> <b>Systematic (<a href="/index.php/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b>
</td></tr>
<tr>
<td bgcolor="#eeeeee" style="text-align: center; vertical-align: top;" colspan="2"> <span style="font-size:11px">(1<i>S</i>,2<i>S</i>)-2-methylamino-1-phenylpropan-1-ol</span>
</td></tr>












<tr>
<td colspan="2" bgcolor="#dddddd"> <b>Identifiers</b>
</td></tr>
<tr>
<td bgcolor="#ddeeff" width="90"> <a href="/index.php/CAS_registry_number" title="CAS registry number">CAS number</a>
</td><td bgcolor="#eeeeee"> <span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=90-82-4&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=90-82-4&amp;rn=1" rel="nofollow">90-82-4</a></span>
</td></tr>
<tr>
<td bgcolor="#ddeeff"> <a href="/index.php/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a>
</td><td bgcolor="#eeeeee"> <a href="/index.php/ATC_code_R01" title="ATC code R01">R01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=R01BA02" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=R01BA02" rel="nofollow">BA02</a></span>
</td></tr>
<tr>
<td bgcolor="#ddeeff"> <a href="/index.php/PubChem" title="PubChem">PubChem</a>
</td><td bgcolor="#eeeeee"> <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=7028" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=7028" rel="nofollow">7028</a></span>
</td></tr>
<tr>
<td bgcolor="#ddeeff"> <a href="/index.php/DrugBank" title="DrugBank">DrugBank</a>
</td><td bgcolor="#eeeeee"> <span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00634" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00634" rel="nofollow">APRD00634</a></span>
</td></tr>
<tr>
<td colspan="2" bgcolor="#dddddd"> <b>Chemical data</b>
</td></tr>
<tr>
<td bgcolor="#ddeeff"> <a href="/index.php/Chemical_formula" title="Chemical formula">Formula</a> </td><td bgcolor="#eeeeee"> <a href="/index.php/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>10</sub><a href="/index.php/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>15</sub><a href="/index.php/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/index.php/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sup>&nbsp;</sup>
</td></tr>
<tr>
<td bgcolor="#ddeeff"> <a href="/index.php/Molecular_mass" title="Molecular mass">Mol. mass</a> </td><td bgcolor="#eeeeee"> 165.23
</td></tr>


















<tr>
<td colspan="2" bgcolor="#dddddd"> <b>Pharmacokinetic data</b>
</td></tr>
<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Bioavailability" title="Bioavailability">Bioavailability</a> </td><td bgcolor="#eeeeee"> unknown
</td></tr>
<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Drug_metabolism" title="Drug metabolism">Metabolism</a> </td><td bgcolor="#eeeeee"> <a href="/index.php/Hepatic" class="mw-redirect" title="Hepatic">hepatic</a> (10–30%)
</td></tr>
<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Biological_half-life" title="Biological half-life">Half life</a> </td><td bgcolor="#eeeeee"> 9–16 hours
</td></tr>
<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Excretion" title="Excretion">Excretion</a> </td><td bgcolor="#eeeeee"> 70-90% <a href="/index.php/Renal" class="mw-redirect" title="Renal">renal</a>
</td></tr>
<tr>
<td colspan="2" bgcolor="#dddddd"> <b>Therapeutic considerations</b>
</td></tr>



<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a>
</td><td bgcolor="#eeeeee">
<p>B2<small>(<a href="/index.php/Australia" title="Australia">AU</a>) </small>
</p>
</td></tr>
<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a>
</td><td bgcolor="#eeeeee">
<p><a href="/index.php/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_3_Pharmacist_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons">Pharmacist Only (S3)</a><small>(<a href="/index.php/Australia" title="Australia">AU</a>) </small>P<small>(<a href="/index.php/United_Kingdom" title="United Kingdom">UK</a>) </small>
</p>
</td></tr>


<tr>
<td bgcolor="#ddeeff" style="vertical-align: top;"> <a href="/index.php/Route_of_administration" title="Route of administration">Routes</a>
</td><td bgcolor="#eeeeee"> oral
</td></tr>
</table>
<p><b>Editor-In-Chief:</b> <a href="/index.php/User:C_Michael_Gibson" title="User:C Michael Gibson">C. Michael Gibson, M.S., M.D.</a> <a href="mailto:mgibson@perfuse.org" class="external autonumber" title="mailto:mgibson@perfuse.org" rel="nofollow">[1]</a> Phone:617-632-7753
</p><p><b>Please Take Over This Page and Apply to be Editor-In-Chief for this topic:</b> 
<small>There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us <a href="mailto:mgibson@perfuse.org" class="external autonumber" title="mailto:mgibson@perfuse.org" rel="nofollow">[2]</a> to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. </small>
</p><p><b>Pseudoephedrine</b> (commonly abbreviated as PSE) is a <a href="/index.php/Sympathomimetic_amine" title="Sympathomimetic amine">sympathomimetic</a> <a href="/index.php/Amine" title="Amine">amine</a> commonly used as a <a href="/index.php/Decongestant" title="Decongestant">decongestant</a>. The salts <b>pseudoephedrine hydrochloride</b> and <b>pseudoephedrine sulfate</b> are found in many <a href="/index.php/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter</a> preparations either as single-ingredient preparations, or more commonly in combination with <a href="/index.php/Antihistamine" title="Antihistamine">antihistamines</a>, <a href="/index.php/Paracetamol" class="mw-redirect" title="Paracetamol">paracetamol</a> and/or <a href="/index.php/Ibuprofen" title="Ibuprofen">ibuprofen</a>. Consumers in North America, the United Kingdom, and Australia often refer to it as <i><a href="/index.php/Sudafed" title="Sudafed">Sudafed</a></i>, the <a href="/index.php?title=Trademark&amp;action=edit&amp;redlink=1" class="new" title="Trademark (not yet written)">trademark</a> for a common brand of pseudoephedrine hydrochloride, although <a href="/index.php/Pfizer" title="Pfizer">Pfizer</a> now sells products without pseudoephedrine under the brand name (as <a href="/index.php/Sudafed_PE" class="mw-redirect" title="Sudafed PE">Sudafed PE</a>).
</p><p>Unlike <a href="/index.php/Antihistamine" title="Antihistamine">antihistamines</a>, which modify the systemic <a href="/index.php/Histamine" title="Histamine">histamine</a>-mediated <a href="/index.php/Allergy" title="Allergy">allergic</a> response, pseudoephedrine only relieves <a href="/index.php/Nasal_congestion" title="Nasal congestion">nasal congestion</a> commonly associated with <a href="/index.php/Common_cold" class="mw-redirect" title="Common cold">colds</a> or <a href="/index.php/Allergy" title="Allergy">allergies</a>. However, some users report rapid and effective relief from other allergic symptoms, including itchy and/or watery eyes, which may not have been provided effectively by antihistamines.
</p><p>The advantage of oral pseudoephedrine over topical nasal preparations, such as <a href="/index.php/Oxymetazoline" title="Oxymetazoline">oxymetazoline</a>, is that it does not cause rebound congestion (<a href="/index.php/Rhinitis_medicamentosa" title="Rhinitis medicamentosa">rhinitis medicamentosa</a>); however, it is more likely to cause adverse effects including <a href="/index.php/Hypertension" title="Hypertension">hypertension</a>.
</p>
<a name="Chemistry"></a><h2> <span class="mw-headline">Chemistry</span></h2>
<p>Pseudoephedrine is a <a href="/index.php/Phenethylamine" title="Phenethylamine">phenethylamine</a>, and a <a href="/index.php/Diastereomer" title="Diastereomer">diastereomer</a> of <a href="/index.php/Ephedrine" title="Ephedrine">ephedrine</a>. Pseudoephedrine is a <a href="/index.php/Chirality_%28chemistry%29" title="Chirality (chemistry)">chiral</a> molecule, meaning it occurs in both "left-handed" and "right-handed" configurations which are not superimposable.
</p><p>Pseudoephedrine is the <a href="/index.php/International_Nonproprietary_Name" title="International Nonproprietary Name">International Nonproprietary Name</a> (INN) of the (1<i>S</i>,2<i>S</i>)- <a href="/index.php/Diastereomer" title="Diastereomer">diastereomer</a> of <a href="/index.php/Ephedrine" title="Ephedrine">ephedrine</a> (which has 1<i>R</i>,2<i>S</i>- configuration). Other names are (+)-pseudoephedrine and <b><small>D</small>-pseudoephedrine</b> (Reynolds, 1989). 
</p><p><b><small>L</small>-Pseudoephedrine</b>, also known as (-)-(1<i>R</i>,2<i>R</i>)-pseudoephedrine or (-)-pseudoephedrine, is the <a href="/index.php/Optical_isomer" class="mw-redirect" title="Optical isomer">optical isomer</a> of <small>D</small>-pseudoephedrine. It has fewer side-effects, fewer <a href="/index.php/Central_nervous_system" title="Central nervous system">central nervous system</a> (CNS) stimulatory effects, does not reduce to <small>D</small>-<a href="/index.php/Methamphetamine" title="Methamphetamine">methamphetamine</a> (which is the enatiomer used as a recreational drug), and yet it retains its efficacy as a decongestant. However, the patent holder for <small>L</small>-pseudoephedrine (Pfizer/Warner-Lambert) has not yet sought or received government approval for its sale to the public.  (<a href="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6495529" class="external text" title="http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6495529" rel="nofollow">U.S. Patent 6,495,529</a><span class="PDFlink noprint"><a href="http://www.pat2pdf.org/pat2pdf/foo.pl?number=6495529" class="external text" title="http://www.pat2pdf.org/pat2pdf/foo.pl?number=6495529" rel="nofollow">&nbsp;</a></span>)
</p>
<a name="Mode_of_action"></a><h2> <span class="mw-headline">Mode of action</span></h2>
<p>Pseudoephedrine is a <a href="/index.php/Sympathomimetic" class="mw-redirect" title="Sympathomimetic">sympathomimetic</a> <a href="/index.php/Amine" title="Amine">amine</a> — that is, its principal mechanism of action relies on its indirect action on the <a href="/index.php/Adrenergic_receptor" title="Adrenergic receptor">adrenergic receptor</a> system. While it may have weak <a href="/index.php/Agonist" title="Agonist">agonist</a> activity at α- and β-adrenergic receptors, the principal mechanism is to displace <a href="/index.php/Noradrenaline" class="mw-redirect" title="Noradrenaline">noradrenaline</a> from storage <a href="/index.php/Vesicle_%28biology%29" title="Vesicle (biology)">vesicles</a> in <a href="/index.php/Presynaptic" class="mw-redirect" title="Presynaptic">presynaptic</a> <a href="/index.php/Neurons" class="mw-redirect" title="Neurons">neurons</a>. The displaced noradrenaline is released into the neuronal <a href="/index.php/Synapse" class="mw-redirect" title="Synapse">synapse</a> where it is free to activate the aforementioned <a href="/index.php/Postsynaptic" class="mw-redirect" title="Postsynaptic">postsynaptic</a> adrenergic receptors.
</p><p>These adrenergic receptors are located on the muscles lining the walls of blood vessels.  When activiated by pseudoephedrine, the muscles contract, causing the blood vessels to constrict (vasoconstriction).  These constricted blood vessels now allow less fluid to leave the blood vessels and enter the nose, throat and sinus linings, which results in decreased inflammation of nasal membranes as well as decreased mucous production.  Thus, by constriction of blood vessels, mainly those located in the nasal passages, pseudoephedrine causes a decrease in the symptoms of nasal congestion.
</p><p>The <a href="/index.php/Vasoconstriction" title="Vasoconstriction">vasoconstriction</a> that pseudoephedrine produces is believed to be principally an α-adrenergic receptor response. While all sympathomimetic amines, to some extent, have decongestant action, pseudoephedrine shows greater selectivity for the nasal mucosa and a lower affinity for <a href="/index.php/Central_nervous_system" title="Central nervous system">central nervous system</a> (CNS) adrenergic-receptors than other sympathomimetic amines.
</p><p><a href="/index.php/Vasoconstriction" title="Vasoconstriction">Vasoconstriction</a> in the nasal mucosa shrinks swollen nasal mucous membranes, reduces tissue <a href="/index.php/Hyperaemia" title="Hyperaemia">hyperaemia</a>, <a href="/index.php/Oedema" class="mw-redirect" title="Oedema">oedema</a>, and nasal congestion. Other beneficial effects may include increasing the drainage of <a href="/index.php/Sinus" title="Sinus">sinus</a> secretions, and opening of obstructed <a href="/index.php/Eustachian_tube" title="Eustachian tube">Eustachian tubes</a>.  The same vasoconstriction action can also result in hypertension, which is a noted side effect of pseudoephedrine.
</p>
<a name="Clinical_use"></a><h2> <span class="mw-headline">Clinical use</span></h2>
<a name="Indications"></a><h3> <span class="mw-headline">Indications</span></h3>
<p>Pseudoephedrine is indicated for the treatment of:
</p>
<ul><li>nasal congestion
</li><li>sinus congestion
</li><li><a href="/index.php/Eustachian_tube" title="Eustachian tube">Eustachian tube</a> congestion. (Bicopoulos, 2002)
</li></ul>
<p>Pseudoephedrine is also indicated for <a href="/index.php/Vasomotor_rhinitis" title="Vasomotor rhinitis">vasomotor rhinitis</a>, and as an adjunct to other agents in the optimum treatment of <a href="/index.php/Allergic_rhinitis" class="mw-redirect" title="Allergic rhinitis">allergic rhinitis</a>, <a href="/index.php/Croup" title="Croup">croup</a>, <a href="/index.php/Sinusitis" title="Sinusitis">sinusitis</a>, <a href="/index.php/Otitis_media" title="Otitis media">otitis media</a>, and <a href="/index.php/Tracheobronchitis" class="mw-redirect" title="Tracheobronchitis">tracheobronchitis</a>. (Bicopoulos, 2002)
</p><p>Pseudoephedrine is also used as first-line therapy of <a href="/index.php/Priapism" title="Priapism">priapism</a>. <a href="/index.php/Erection" title="Erection">Erection</a> is largely a <a href="/index.php/Autonomic_nervous_system" title="Autonomic nervous system">parasympathetic</a> response, so the sympathetic action of pseudoephedrine may serve to relieve this condition.
</p><p>Treatment for urinary incontinence is an unlabeled use for these medications. Unlabeled use means doctors can use the medication to treat a condition other than that for which it was first approved by the U.S. Food and Drug Administration (FDA). These medications are approved by the FDA for the treatment of nasal congestion caused by colds or allergies. However it has also been successful in treating stress incontinence by increasing the pressure (tension) exerted by the muscles of the bladder neck and the urethra, which helps retain the urine within the bladder.
</p>
<a name="Adverse_effects"></a><h3> <span class="mw-headline">Adverse effects</span></h3>
<p>Common adverse drug reactions (ADRs) associated with pseudoephedrine therapy include: <a href="/index.php/Central_nervous_system" title="Central nervous system">CNS</a> stimulation, sleeplessness, nervousness, excitability, dizziness and anxiety. Infrequent ADRs include: <a href="/index.php/Tachycardia" title="Tachycardia">tachycardia</a> and/or <a href="/index.php/Palpitation" title="Palpitation">palpitations</a>. Rarely, pseudoephedrine therapy may be associated with <a href="/index.php/Hallucination" title="Hallucination">hallucinations</a>, <a href="/index.php/Arrhythmia" class="mw-redirect" title="Arrhythmia">arrhythmias</a>, <a href="/index.php/Hypertension" title="Hypertension">hypertension</a>, seizures and <a href="/index.php/Ischemic_colitis" title="Ischemic colitis">ischemic colitis</a> (Rossi, 2006); as well as severe skin reactions known as recurrent pseudo-scarlatina, systemic contact dermatitis, and nonpigmenting <a href="/index.php/Fixed_drug_eruption" title="Fixed drug eruption">fixed drug eruption</a> (Vidal, Prieto, Peréz-Carral, Armisén 1998).
</p><p>It has also been reported that pseudoephedrine, amongst other <a href="/index.php/Sympathomimetics" class="mw-redirect" title="Sympathomimetics">sympathomimetic</a> agents, may be associated with the occurrence of <a href="/index.php/Stroke" title="Stroke">stroke</a> (Cantu et al., 2003).
</p>
<a name="Precautions_and_contraindications"></a><h3> <span class="mw-headline">Precautions and contraindications</span></h3>
<p>Pseudoephedrine should be used with caution in patients with: <a href="/index.php/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a>, <a href="/index.php/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>, <a href="/index.php/Hypertension" title="Hypertension">hypertension</a>, <a href="/index.php/Prostatic_hypertrophy" class="mw-redirect" title="Prostatic hypertrophy">prostatic hypertrophy</a>, <a href="/index.php/Hyperthyroidism" title="Hyperthyroidism">hyperthyroidism</a>, <a href="/index.php/Closed_angle_glaucoma" class="mw-redirect" title="Closed angle glaucoma">closed angle glaucoma</a> and/or pregnancy (Rossi, 2006). 
</p><p>Since nasal congestion is considered to be a relatively minor ailment, alternatives are preferred in patients with these conditions. Appropriate alternatives may include topical decongestants or <a href="/index.php/Saline" class="mw-redirect" title="Saline">saline</a> sprays/instillations, depending on the patient's condition.
</p><p>Contraindications for the use of pseudoephedrine include: concomitant or recent (previous fourteen days) <a href="/index.php/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">monoamine oxidase inhibitor</a> (MAOI) therapy, severe or uncontrolled hypertension, and/or severe coronary artery disease (Rossi, 2006).
</p><p>People with <a href="/index.php/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a> should use care when taking pseudoephedrine, as it can cause insomnia and thus trigger a manic episode.
</p>
<a name="Chiral_auxiliary"></a><h2> <span class="mw-headline">Chiral auxiliary</span></h2>
<p>Both (R,R)- and (S,S)-pseudoephedrine are used as a <a href="/index.php/Chiral_auxiliary" title="Chiral auxiliary">chiral auxiliary</a>.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup>
Pseudoephedrine is reacted with a <a href="/index.php/Carboxylic_acid" title="Carboxylic acid">carboxylic acid</a>, <a href="/index.php/Acid_anhydride" title="Acid anhydride">acid anhydride</a>, or <a href="/index.php/Acyl_chloride" title="Acyl chloride">acyl chloride</a> to give a pseudoephedrine amide.
</p><p>The α-proton of the carbonyl compound is easily deprotonated by a <a href="/index.php/Non-nucleophilic_base" title="Non-nucleophilic base">non-nucleophilic base</a> to give the enolate, which can further react. The configuration of the addition compound, such as with an <a href="/index.php/Alkyl_halide" class="mw-redirect" title="Alkyl halide">alkyl halide</a>, is directed by the methyl group. Thus, any addition product will be anti to the methyl and syn with the <a href="/index.php/Hydroxyl_group" class="mw-redirect" title="Hydroxyl group">hydroxyl group</a>.
</p><p>The pseudoephedrine chiral auxiliary is subsequently removed by cleaving the amide bond with an appropriate <a href="/index.php/Nucleophile" title="Nucleophile">nucleophile</a>.
</p>
<a name="Manufacture"></a><h2> <span class="mw-headline">Manufacture</span></h2>
<p>Although pseudoephedrine occurs naturally as an <a href="/index.php/Alkaloid" title="Alkaloid">alkaloid</a> in certain plant species (for example, as a constituent of extracts from the <a href="/index.php/Ephedra" title="Ephedra">ephedra</a> species, also known as <a href="/index.php/Ma_Huang" class="mw-redirect" title="Ma Huang">Ma Huang</a>, in which it occurs together with other isomers of <a href="/index.php/Ephedrine" title="Ephedrine">ephedrine</a>), the majority of pseudoephedrine produced for commercial use is derived from <a href="/index.php/Yeast" title="Yeast">yeast</a> fermentation of <a href="/index.php/Dextrose" class="mw-redirect" title="Dextrose">dextrose</a> in the presence of <a href="/index.php/Benzaldehyde" title="Benzaldehyde">benzaldehyde</a>.  In this process, specialized strains of yeast (typically a variety of <i><a href="/index.php?title=Candida_utilis&amp;action=edit&amp;redlink=1" class="new" title="Candida utilis (not yet written)">Candida utilis</a></i> or <i><a href="/index.php/Saccharomyces_cerevisiae" title="Saccharomyces cerevisiae">Saccharomyces cerevisiae</a></i>) are added to large vats containing water, dextrose and the enzyme <a href="/index.php/Pyruvate_decarboxylase" title="Pyruvate decarboxylase">pyruvate decarboxylase</a> (such as found in <a href="/index.php/Beet" title="Beet">beets</a> and other plants).  After the yeast has begun fermenting the dextrose, the benzaldehyde is added to the vats, and in this environment the yeast convert the precursor ingredients to <a href="/index.php?title=L-phenylacetylcarbinol&amp;action=edit&amp;redlink=1" class="new" title="L-phenylacetylcarbinol (not yet written)">l-phenylacetylcarbinol</a> (L-PAC).  L-PAC is then chemically converted to pseudoephedrine via reductive <a href="/index.php/Amination" title="Amination">amination</a> (Oliver, 1999).
</p><p>The bulk of pseudoephedrine is produced by commercial pharmaceutical manufacturers in <a href="/index.php?title=India&amp;action=edit&amp;redlink=1" class="new" title="India (not yet written)">India</a> and <a href="/index.php?title=China&amp;action=edit&amp;redlink=1" class="new" title="China (not yet written)">China</a>, where economic and industrial conditions favor the mass production of pseudoephedrine for export (Suo, 2004).
</p>
<a name="Misuse_and_illicit_use"></a><h2> <span class="mw-headline">Misuse and illicit use</span></h2>
<p>There have also been reports of off-label uses of pseudoephedrine for its stimulant properties. Some patients, long-distance truck drivers and sports athletes for example, have reportedly used pseudoephedrine as a stimulant to increase their state of alertness/awakedness. It is doubtful that pseudoephedrine would be of significant benefit, except in sensitive individuals, because of its minimal effect in the <a href="/index.php/Central_nervous_system" title="Central nervous system">central nervous system</a> (see Mode of Action above). Nevertheless, such misuse of pseudoephedrine has been associated with stimulant <a href="/index.php/Drug_dependence" class="mw-redirect" title="Drug dependence">dependence</a>.  The similarity in chemical structure to the <a href="/index.php/Amphetamine" title="Amphetamine">amphetamines</a> has made pseudoephedrine a sought-after chemical precursor in the <a href="/index.php/Clandestine_chemistry" title="Clandestine chemistry">illicit manufacture</a> of <a href="/index.php/Methamphetamine" title="Methamphetamine">methamphetamine</a> and <a href="/index.php/Methcathinone" title="Methcathinone">methcathinone</a>.  As a result of the increasing regulatory restrictions on the sale and distribution of pseudoephedrine, many pharmaceutical firms have reformulated, or are in the process of reformulating medications to use alternative decongestants, such as <a href="/index.php/Phenylephrine" title="Phenylephrine">phenylephrine</a>.  Many retailers such as <a href="/index.php?title=Target_Corporation&amp;action=edit&amp;redlink=1" class="new" title="Target Corporation (not yet written)">Target</a>, <a href="/index.php?title=Wal-Mart&amp;action=edit&amp;redlink=1" class="new" title="Wal-Mart (not yet written)">Wal-Mart</a>, <a href="/index.php?title=CVS&amp;action=edit&amp;redlink=1" class="new" title="CVS (not yet written)">CVS</a>, and <a href="/index.php?title=Winn-Dixie&amp;action=edit&amp;redlink=1" class="new" title="Winn-Dixie (not yet written)">Winn-Dixie</a> have created corporate policies restricting the sale of pseudoephedrine-containing products.  Their policies restrict sales by limiting purchase quantities and requiring a minimum age with proper identification.  These requirements are similar to and sometimes more stringent than existing law.  Internationally, pseudoephedrine is listed as a Table I precursor under the <a href="/index.php/United_Nations_Convention_Against_Illicit_Traffic_in_Narcotic_Drugs_and_Psychotropic_Substances" title="United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances">United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances</a>.<a href="http://www.incb.org/pdf/e/list/red.pdf" class="external autonumber" title="http://www.incb.org/pdf/e/list/red.pdf" rel="nofollow">[3]</a>
</p>
<a name="United_States_federal_law"></a><h3> <span class="mw-headline">United States federal law</span></h3>
<p>The <a href="/index.php?title=United_States_Congress&amp;action=edit&amp;redlink=1" class="new" title="United States Congress (not yet written)">United States Congress</a> has recognized the use of pseudoephedrine in the illicit manufacture of methamphetamine.  In late <a href="/index.php?title=2005&amp;action=edit&amp;redlink=1" class="new" title="2005 (not yet written)">2005</a>, the <a href="/index.php?title=Committee_on_Education_and_the_Workforce&amp;action=edit&amp;redlink=1" class="new" title="Committee on Education and the Workforce (not yet written)">Committee on Education and the Workforce</a> heard testimony concerning education programs and state legislation designed to curb the use and manufacture of methamphetamine with pseudoephedrine-containing products.  State laws in Oregon and Kansas were particularly influential in the proposed legislation. The <a href="/index.php?title=House&amp;action=edit&amp;redlink=1" class="new" title="House (not yet written)">House</a> passed the <i><a href="/index.php/Combat_Methamphetamine_Epidemic_Act_of_2005" title="Combat Methamphetamine Epidemic Act of 2005">Combat Methamphetamine Epidemic Act of 2005</a></i> ("CMEA") as an amendment to the renewal of the <a href="/index.php?title=Patriot_Act&amp;action=edit&amp;redlink=1" class="new" title="Patriot Act (not yet written)">Patriot Act</a>. Signed into law by president <a href="/index.php?title=George_W._Bush&amp;action=edit&amp;redlink=1" class="new" title="George W. Bush (not yet written)">George W. Bush</a> on March 6, 2006, the act amended the <a href="/index.php?title=US_Code&amp;action=edit&amp;redlink=1" class="new" title="US Code (not yet written)">US Code</a> (21 USC 830) concerning the sale of pseudoephedrine containing products. The Federal statute included the following requirements for merchants ("regulated seller") who sell these products (pseudoephedrine is defined as a "scheduled listed chemical product under 21 USC 802(45(A)):
</p>
<ul><li>A retrievable record of all purchases identifying the name and address of each party to be kept for two years.
</li><li>Required verification of proof of identity of all purchasers
</li><li>Required protection and disclosure methods in the collection of personal information
</li><li>Reports to the <a href="/index.php?title=Attorney_General&amp;action=edit&amp;redlink=1" class="new" title="Attorney General (not yet written)">Attorney General</a> of any suspicious payments or disappearances of the regulated products
</li><li>Required training of employees with regard to the requirements of the CMEA; Retailer must self-certify as to training and compliance
</li><li>Non-liquid dose form of regulated product may only be sold in unit dose blister packs
</li><li>Regulated products are to be sold behind the counter or in a locked cabinet in such a way as to restrict public access
</li><li>Daily sales of regulated products not to exceed 3.6 grams without regard to the number of transactions
</li><li>30 day (not monthly) sales limit not to exceed 7.5 grams if sold by mail-order or "mobile retail vendor"
</li><li>30 day PURCHASE limit not to exceed 9 grams of pseudoephedrine base in regulated products (misdemeanor possession offense under 21 USC 844a for the individual who buys it)
</li></ul>
<a name="United_States_state_law"></a><h3> <span class="mw-headline">United States state law</span></h3>
<p>Individual states also have varying laws on the matter, e.g. <a href="/index.php?title=Alabama&amp;action=edit&amp;redlink=1" class="new" title="Alabama (not yet written)">Alabama</a>, <a href="/index.php?title=Arizona&amp;action=edit&amp;redlink=1" class="new" title="Arizona (not yet written)">Arizona</a>, <a href="/index.php?title=California&amp;action=edit&amp;redlink=1" class="new" title="California (not yet written)">California</a>, <a href="/index.php?title=Connecticut&amp;action=edit&amp;redlink=1" class="new" title="Connecticut (not yet written)">Connecticut</a>, <a href="/index.php?title=Colorado&amp;action=edit&amp;redlink=1" class="new" title="Colorado (not yet written)">Colorado</a>, <a href="/index.php?title=Delaware&amp;action=edit&amp;redlink=1" class="new" title="Delaware (not yet written)">Delaware</a>, <a href="/index.php?title=Georgia_%28U.S._state%29&amp;action=edit&amp;redlink=1" class="new" title="Georgia (U.S. state) (not yet written)">Georgia</a>, <a href="/index.php?title=Florida&amp;action=edit&amp;redlink=1" class="new" title="Florida (not yet written)">Florida</a>, <a href="/index.php?title=Illinois&amp;action=edit&amp;redlink=1" class="new" title="Illinois (not yet written)">Illinois</a>, <a href="/index.php?title=Indiana&amp;action=edit&amp;redlink=1" class="new" title="Indiana (not yet written)">Indiana</a>, <a href="/index.php?title=Iowa&amp;action=edit&amp;redlink=1" class="new" title="Iowa (not yet written)">Iowa</a>, <a href="/index.php?title=Kansas&amp;action=edit&amp;redlink=1" class="new" title="Kansas (not yet written)">Kansas</a>, <a href="/index.php?title=Massachusetts&amp;action=edit&amp;redlink=1" class="new" title="Massachusetts (not yet written)">Massachusetts</a>, <a href="/index.php?title=Maryland&amp;action=edit&amp;redlink=1" class="new" title="Maryland (not yet written)">Maryland</a>, <a href="/index.php?title=Michigan&amp;action=edit&amp;redlink=1" class="new" title="Michigan (not yet written)">Michigan</a>, <a href="/index.php?title=Minnesota&amp;action=edit&amp;redlink=1" class="new" title="Minnesota (not yet written)">Minnesota</a>, <a href="/index.php?title=Missouri&amp;action=edit&amp;redlink=1" class="new" title="Missouri (not yet written)">Missouri</a>, <a href="/index.php?title=Montana&amp;action=edit&amp;redlink=1" class="new" title="Montana (not yet written)">Montana</a>, <a href="/index.php?title=New_Jersey&amp;action=edit&amp;redlink=1" class="new" title="New Jersey (not yet written)">New Jersey</a>, <a href="/index.php?title=New_York&amp;action=edit&amp;redlink=1" class="new" title="New York (not yet written)">New York</a>, <a href="/index.php?title=North_Carolina&amp;action=edit&amp;redlink=1" class="new" title="North Carolina (not yet written)">North Carolina</a>, <a href="/index.php?title=Oklahoma&amp;action=edit&amp;redlink=1" class="new" title="Oklahoma (not yet written)">Oklahoma</a>, <a href="/index.php?title=Pennsylvania&amp;action=edit&amp;redlink=1" class="new" title="Pennsylvania (not yet written)">Pennsylvania</a>, <a href="/index.php?title=Rhode_Island&amp;action=edit&amp;redlink=1" class="new" title="Rhode Island (not yet written)">Rhode Island</a>, <a href="/index.php?title=Tennessee&amp;action=edit&amp;redlink=1" class="new" title="Tennessee (not yet written)">Tennessee</a>, <a href="/index.php?title=Texas&amp;action=edit&amp;redlink=1" class="new" title="Texas (not yet written)">Texas</a>, <a href="/index.php?title=Utah&amp;action=edit&amp;redlink=1" class="new" title="Utah (not yet written)">Utah</a>, <a href="/index.php?title=Vermont&amp;action=edit&amp;redlink=1" class="new" title="Vermont (not yet written)">Vermont</a>, <a href="/index.php?title=Virginia&amp;action=edit&amp;redlink=1" class="new" title="Virginia (not yet written)">Virginia</a>, and <a href="/index.php?title=Washington&amp;action=edit&amp;redlink=1" class="new" title="Washington (not yet written)">Washington</a> laws require pharmacies to sell pseudoephedrine behind-the-counter and to collect personal information from the purchaser.  As of <a href="/index.php?title=July_1&amp;action=edit&amp;redlink=1" class="new" title="July 1 (not yet written)">July 1</a> <a href="/index.php?title=2006&amp;action=edit&amp;redlink=1" class="new" title="2006 (not yet written)">2006</a>, <a href="/index.php?title=Oregon&amp;action=edit&amp;redlink=1" class="new" title="Oregon (not yet written)">Oregon</a> recognizes pseudoephedrine and all pseudoephedrine containing products as a Schedule III controlled substance, and requires a prescription to purchase them.
</p>
<a name="Australia"></a><h3> <span class="mw-headline">Australia</span></h3>
<p>Illicit diversion of pseudoephedrine in Australia has caused significant changes to the way pseudoephedrine products are regulated.  As of <a href="/index.php?title=2006&amp;action=edit&amp;redlink=1" class="new" title="2006 (not yet written)">2006</a>, all products containing pseudoephedrine have been rescheduled as "Pharmacist Only Medicines" (Schedule 3).  As a result, a pharmacist must be directly involved in every transaction involving the sale of pseudoephedrine to members of the public, and such medicines will be kept behind the counter, away from public access.  Such measures are designed to ensure that the medicines are needed for a legitimate purpose.  Pharmacists are also required lodge the purchase with an online database called PROJECTSTOP.  This database records each purchase of pseudoephedrine products, tracking the customers drivers license or 18+ card.  This system was put in place to stop drug mules driving from Sydney to Cairns (a trip of 3000km or 1875mi) purchasing a small box of pseudoephedrine at every pharmacy along the way.  When the database is used 3 modes of sale can be used.  One allows the sale (as "no match" was found), one denies the sale and the third, called a safety sale, is when the product was sold under duress.  Certain preparations containing significantly high amounts of pseudoephedrine are further restricted as "Prescription Only Medicines" (Schedule 4).
</p><p>As of <a href="/index.php?title=April_2007&amp;action=edit&amp;redlink=1" class="new" title="April 2007 (not yet written)">April 2007</a>, the Australian government is considering the prohibition of all medications containing pseudoephedrine. <a href="http://www.abc.net.au/news/newsitems/200704/s1898059.htm" class="external autonumber" title="http://www.abc.net.au/news/newsitems/200704/s1898059.htm" rel="nofollow">[4]</a>
</p>
<a name="New_Zealand"></a><h3> <span class="mw-headline">New Zealand</span></h3>
<p>In New Zealand, from <a href="/index.php?title=15_October&amp;action=edit&amp;redlink=1" class="new" title="15 October (not yet written)">15 October</a> <a href="/index.php?title=2004&amp;action=edit&amp;redlink=1" class="new" title="2004 (not yet written)">2004</a>, as a result of large intercepts of pseudoephedrine and ephedrine, any product containing these substances e.g. cold and flu medicines were classified as Class C controlled drugs in the Misuse of Drugs Act 1975. New Zealand Customs and police officers are continuing to make large interceptions of precursor substances believed to be destined for methamphetamine production.
</p>
<a name="Brand_names"></a><h2> <span class="mw-headline">Brand names</span></h2>
<ul><li>Contac (pseudoephedrine) - Has been discontinued as of 2007
</li><li>Codral (pseudoephedrine HCI)
</li><li>Sudafed (pseudoephedrine) - has an alternate <a href="/index.php?title=Phenylephrine_HCl&amp;action=edit&amp;redlink=1" class="new" title="Phenylephrine HCl (not yet written)">phenylephrine HCl</a> version, Sudafed PE
</li><li><a href="/index.php/Actifed" title="Actifed">Actifed</a> (triprolidine/pseudoephedrine) - no longer contains pseudoephedrine as of 2007
</li><li>Claritin-D (loratadine/pseudoephedrine)
</li><li>Clarinex-D (desloratadine/pseudoephedrine)
</li><li>Sinutab (<a href="/index.php/Paracetamol" class="mw-redirect" title="Paracetamol">Paracetamol</a>/pseudoephedrine)
</li><li>Sinufed (pseudoephedrine HCI)
</li><li>Benylin (pseudoephedrine)
</li><li>Zyrtec-D (certirizine/pseudoephedrine) - Prescription only
</li><li>Allegra-D (fexofenadine/pseudoephedrine) - Prescription only
</li><li>Drixoral (<a href="/index.php/Dexbrompheniramine" title="Dexbrompheniramine">dexbrompheniramine</a>/pseudoephedrine)
</li><li><a href="/index.php?title=Mucinex&amp;action=edit&amp;redlink=1" class="new" title="Mucinex (not yet written)">Mucinex</a>-D (guaifenesin/pseudoephedrine)
</li><li>PediaCare (pseudoephedrine/chlorpheniramine/dextromethorphan)
</li><li>Pannaz (pseudoephedrine/chlorpheniramine/methscopolamine)
</li><li>Fludrex (pseudoephedrine/dextromethorphan/triprolidine)
</li><li>Solpa-Sinus (pseudoephedrine/<a href="/index.php/Acetaminophen" class="mw-redirect" title="Acetaminophen">acetaminophen</a>)
</li><li>Advil Cold and Sinus (pseudoephedrine/<a href="/index.php/Ibuprofen" title="Ibuprofen">ibuprofen</a>)
</li><li>Tylenol Sinus (pseudoephedrine/<a href="/index.php/Acetaminophen" class="mw-redirect" title="Acetaminophen">acetaminophen</a>)
</li></ul>
<a name="References"></a><h2> <span class="mw-headline">References</span></h2>
<ol class="references"><li id="_note-0"><a href="#_ref-0" title="">↑</a> Myers, A. G., et al, <i>Pseudoephedrine as a Practical Chiral Auxiliary for the Synthesis of Highly Enantiomerically Enriched Carboxylic Acids, Alcohols, Aldehydes, and Ketones</i>, <a href="/index.php?title=J._Am._Chem._Soc.&amp;action=edit&amp;redlink=1" class="new" title="J. Am. Chem. Soc. (not yet written)">J. Am. Chem. Soc.</a>, <b>1997</b>, <i>119</i>, 6460-6651.</li></ol>
<ul><li> Bicopoulos D, editor. AusDI: Drug information for the healthcare professional, 2nd edition. Castle Hill: Pharmaceutical Care Information Services; 2002.
</li><li> Cantu C, Arauz A, Murillo-Bonilla LM, Lopez M, Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke 2003;34(7):1667-72. PMID: 12791938
</li><li> <cite class="book" style="font-style:normal">&#32;(1989)&#32;in Edited by Reynolds JEF:<a href="/index.php?title=Template:Cite_book/editor&amp;action=edit&amp;redlink=1" class="new" title="Template:Cite book/editor (not yet written)"> </a> <i><a href="/index.php/Martindale:_The_complete_drug_reference" title="Martindale: The complete drug reference">Martindale: The complete drug reference</a></i>, 29th edition,&#32;London:&#32;Pharmaceutical Press. <a href="/index.php/Special:BookSources/0853692106" class="internal">ISBN 0-85369-210-6</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=%5B%5BMartindale%3A+The+complete+drug+reference%5D%5D&amp;rft.date=1989&amp;rft.edition=29th+edition&amp;rft.pub=Pharmaceutical+Press&amp;rft.place=London">&nbsp;</span>
</li><li> Rossi S, editor. <a href="/index.php/Australian_Medicines_Handbook" title="Australian Medicines Handbook">Australian Medicines Handbook</a> 2006. Adelaide: Australian Medicines Handbook; 2006. <a href="/index.php/Special:BookSources/0975791923" class="internal">ISBN 0-9757919-2-3</a>
</li><li> Oliver AL, Anderson BN, Roddick FA. Factors affecting the production of L-phenylacetylcarbinol by yeast: a case study. Advances in Microbial Physiology. 1999;41:1-45. PMID: 10500843
</li><li> Suo, Steve. Clamp down on shipments of raw ingredients. The Oregonian; <a href="/index.php?title=6_October&amp;action=edit&amp;redlink=1" class="new" title="6 October (not yet written)">6 October</a> <a href="/index.php?title=2004&amp;action=edit&amp;redlink=1" class="new" title="2004 (not yet written)">2004</a>. From a version reprinted on a U.S. <a href="http://www.house.gov/larsen/meth/press_20041006_oregonian_clampdown.shtml" class="external text" title="http://www.house.gov/larsen/meth/press_20041006_oregonian_clampdown.shtml" rel="nofollow">congressional caucus</a> website.
</li><li> U.S. Patent 6,495,529, (-)-Pseudoephedrine as a Sympathomimetic Drug, Warner-Lambert (2002).
</li><li> <a href="http://www.leg.state.or.us/05reg/measures/hb2400.dir/hb2485.en.html" class="external text" title="http://www.leg.state.or.us/05reg/measures/hb2400.dir/hb2485.en.html" rel="nofollow">Oregon House Bill 2485</a>
</li><li> WebMD <a href="http://www.webmd.com/hw/urinary_control/hw219741.asp" class="external autonumber" title="http://www.webmd.com/hw/urinary_control/hw219741.asp" rel="nofollow">[5]</a>
</li><li> Vidal C, MD; Prieto A, MD; Peréz-Carral C, MD; and Armisén M, MD. Nonpigmenting fixed drug eruption due to pseudoephedrine. Annals of Allergy, Asthma, &amp; Immunology 1998.
</li></ul>
<a name="See_also"></a><h2> <span class="mw-headline">See also</span></h2>
<ul><li> <a href="/index.php/Ephedrine" title="Ephedrine">Ephedrine</a>
</li><li> <a href="/index.php/Phenylephrine" title="Phenylephrine">Phenylephrine</a> - a substitute used where pseudoephedrine sale is restricted by law
</li><li> <a href="/index.php/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a>
</li><li> <a href="/index.php/Amphetamine" title="Amphetamine">Amphetamine</a>
</li><li> <a href="/index.php/Methamphetamine" title="Methamphetamine">Methamphetamine</a>
</li><li> <a href="/index.php/Methcathinone" title="Methcathinone">Methcathinone</a>
</li><li> <a href="/index.php/Phenethylamine" title="Phenethylamine">Phenethylamines</a>
</li></ul>
<a name="External_links"></a><h2> <span class="mw-headline">External links</span></h2>
<ul><li> <a href="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202489.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202489.html" rel="nofollow">Pseudoephedrine (Systemic) monograph</a> – from <i>USP DI Advice for the Patient</i>
</li><li> <a href="http://redpoll.pharmacy.ualberta.ca/drugbank/drugBank/drugFile/msds/APRD00634.html" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/drugBank/drugFile/msds/APRD00634.html" rel="nofollow">Pseudoephedrine MSDS (Material Safety Data Sheet)</a>
</li></ul>
<table class="navbox collapsible autocollapse nowraplinks" style="margin:auto; background:white;background:white;"><tr><th colspan="2" style="text-align:center;width:100%;"><div style="float:left; width:6em; text-align:left;"><div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; white-space:nowrap; font-weight:normal; font-size:xx-small;&nbsp;;border:none;;"><a href="/index.php/Template:Nasal_preparations" title="Template:Nasal preparations"><span title="View this template" style=";border:none;;">v</span></a>&nbsp;<span style="font-size:80%;">•</span>&nbsp;<a href="/index.php?title=Template_talk:Nasal_preparations&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Nasal preparations (not yet written)"><span style="color:#002bb8;;border:none;;" title="Discussion about this template">d</span></a>&nbsp;<span style="font-size:80%;">•</span>&nbsp;<a href="http://wikidoc.org/index.php?title=Template:Nasal_preparations&amp;action=edit" class="external text" title="http://wikidoc.org/index.php?title=Template:Nasal_preparations&amp;action=edit" rel="nofollow"><span style="color:#002bb8;;border:none;;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div></div><span style="font-size:110%;"><a href="/index.php/Decongestant" title="Decongestant">Decongestants</a> and other nasal preparations (<a href="/index.php/ATC_code_R01" title="ATC code R01">R01</a>)</span></th></tr><tr><th style="white-space:nowrap;background:#ddddff;text-align:right;background:MistyRose;">Topical: <a href="/index.php/Sympathomimetic" class="mw-redirect" title="Sympathomimetic">sympathomimetics</a>, plain</th><td colspan="1" style="text-align:left;width:100%;font-size:95%;"><a href="/index.php/Cyclopentamine" title="Cyclopentamine">Cyclopentamine</a> - <a href="/index.php/Ephedrine" title="Ephedrine">Ephedrine</a> - <a href="/index.php/Phenylephrine" title="Phenylephrine">Phenylephrine</a> - <a href="/index.php/Oxymetazoline" title="Oxymetazoline">Oxymetazoline</a> - <a href="/index.php/Tetryzoline" class="mw-redirect" title="Tetryzoline">Tetryzoline</a> - <a href="/index.php/Xylometazoline" title="Xylometazoline">Xylometazoline</a> - <a href="/index.php/Naphazoline" title="Naphazoline">Naphazoline</a> - <a href="/index.php/Tramazoline" title="Tramazoline">Tramazoline</a> - <a href="/index.php/Metizoline" title="Metizoline">Metizoline</a> - <a href="/index.php/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a> - <a href="/index.php/Fenoxazoline" title="Fenoxazoline">Fenoxazoline</a> - <a href="/index.php/Tymazoline" title="Tymazoline">Tymazoline</a> - <a href="/index.php/Epinephrine" title="Epinephrine">Epinephrine</a></td></tr><tr><th style="white-space:nowrap;background:#ddddff;text-align:right;background:MistyRose;">Topical: <a href="/index.php/Antiallergic" class="mw-redirect" title="Antiallergic">antiallergic</a> agents, excluding corticosteroids</th><td colspan="1" style="text-align:left;width:100%;font-size:95%;background:#f7f7f7;"><a href="/index.php/Cromoglicate" title="Cromoglicate">Cromoglicic acid</a> - <a href="/index.php/Levocabastine" title="Levocabastine">Levocabastine</a> - <a href="/index.php/Azelastine" title="Azelastine">Azelastine</a> - <a href="/index.php/Antazoline" title="Antazoline">Antazoline</a> - <a href="/index.php/Spaglumic_acid" class="mw-redirect" title="Spaglumic acid">Spaglumic acid</a> - <a href="/index.php/Thonzylamine" title="Thonzylamine">Thonzylamine</a> - <a href="/index.php/Nedocromil" title="Nedocromil">Nedocromil</a> - <a href="/index.php/Olopatadine" title="Olopatadine">Olopatadine</a></td></tr><tr><th style="white-space:nowrap;background:#ddddff;text-align:right;background:MistyRose;">Topical: <a href="/index.php/Corticosteroid" title="Corticosteroid">corticosteroids</a></th><td colspan="1" style="text-align:left;width:100%;font-size:95%;"><a href="/index.php/Beclometasone_dipropionate" title="Beclometasone dipropionate">Beclometasone</a> - <a href="/index.php/Prednisolone" title="Prednisolone">Prednisolone</a> - <a href="/index.php/Dexamethasone" title="Dexamethasone">Dexamethasone</a> - <a href="/index.php/Flunisolide" title="Flunisolide">Flunisolide</a> - <a href="/index.php/Budesonide" title="Budesonide">Budesonide</a> - <a href="/index.php/Betamethasone" title="Betamethasone">Betamethasone</a> - <a href="/index.php/Tixocortol" title="Tixocortol">Tixocortol</a> - <a href="/index.php/Fluticasone" title="Fluticasone">Fluticasone</a> - <a href="/index.php/Mometasone_furoate" title="Mometasone furoate">Mometasone furoate</a> - <a href="/index.php/Triamcinolone" title="Triamcinolone">Triamcinolone</a> - <a href="/index.php/Ciclesonide" title="Ciclesonide">Ciclesonide</a></td></tr><tr><th style="white-space:nowrap;background:#ddddff;text-align:right;background:MistyRose;">Topical: other nasal preparations</th><td colspan="1" style="text-align:left;width:100%;font-size:95%;background:#f7f7f7;"><a href="/index.php/Calcium_hexamine_thiocyanate" title="Calcium hexamine thiocyanate">Calcium hexamine thiocyanate</a> - <a href="/index.php/Retinol" title="Retinol">Retinol</a> - <a href="/index.php/Ipratropium" title="Ipratropium">Ipratropium bromide</a> - <a href="/index.php/Ritiometan" title="Ritiometan">Ritiometan</a> - <a href="/index.php/Mupirocin" title="Mupirocin">Mupirocin</a> - <a href="/index.php/Hexamidine" title="Hexamidine">Hexamidine</a> - <a href="/index.php/Framycetin" title="Framycetin">Framycetin</a></td></tr><tr><th style="white-space:nowrap;background:#ddddff;text-align:right;background:MistyRose;">Systemic use: <a href="/index.php/Sympathomimetic" class="mw-redirect" title="Sympathomimetic">Sympathomimetics</a></th><td colspan="1" style="text-align:left;width:100%;font-size:95%;"><a href="/index.php/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a> - <strong class="selflink">Pseudoephedrine</strong> - <a href="/index.php/Phenylephrine" title="Phenylephrine">Phenylephrine</a></td></tr></table>
<p><br>
<a href="/index.php?title=De:Pseudoephedrin&amp;action=edit&amp;redlink=1" class="new" title="De:Pseudoephedrin (not yet written)">de:Pseudoephedrin</a><a href="/index.php?title=Hu:Pszeudoefedrin&amp;action=edit&amp;redlink=1" class="new" title="Hu:Pszeudoefedrin (not yet written)">hu:Pszeudoefedrin</a>
<a href="/index.php?title=Nl:Pseudo-efedrine&amp;action=edit&amp;redlink=1" class="new" title="Nl:Pseudo-efedrine (not yet written)">nl:Pseudo-efedrine</a>
</p>
<!-- Tidy found serious XHTML errors -->

<!-- 
NewPP limit report
Preprocessor node count: 2587/1000000
Post-expand include size: 26702/2097152 bytes
Template argument size: 9061/2097152 bytes
Expensive parser function count: 0/100
-->

<!-- Saved in parser cache with key wikidb-wd_:pcache:idhash:8588-0!1!0!!en!2!edit=0 and timestamp 20101221092546 -->

<div><br />
</p>
<table style="border-spacing:12px" align="center">

<tr valign="top">
<td>
<table style="border:solid 2px #DDDDCC;font-size:90%;padding:2px;width:590px" cellspacing="0">
<tr>
<td style="text-align:center;background:#EEEEDD;padding:3px" colspan="2"> <b>WikiDoc Help Menu</b>
</td></tr>
<tr>
<td style="background:#FFFFEE;padding:7px;width:50%" valign="top">
<p><b>Quick Start.. </b>
</p>
<ul><li><a href="/index.php/Help:Get_Started_Here%21" title="Help:Get Started Here!">Get Started Here!</a>
</li><li><a href="/index.php/Help:Login" title="Help:Login">How to Login</a>
</li><li><a href="/index.php/Help:Searching" title="Help:Searching">How to Search Pages</a> 
</li><li><a href="/index.php/Help:Create_a_New_Page" title="Help:Create a New Page">How to Start a New Page</a>
</li><li><a href="/index.php/Help:How_to_Edit_a_Page" title="Help:How to Edit a Page">How to Edit a Page</a>
</li><li><a href="/index.php/Help:Cheat_Sheet" title="Help:Cheat Sheet">Cheat Sheet</a>
</li></ul>
<p><b>Editing basics</b>
</p>
<ul><li><a href="/index.php/Help:Basic_Formatting" title="Help:Basic Formatting">Learning Basic Formatting</a>
</li><li><a href="/index.php/Help:Links" title="Help:Links">How to make Links in WikiDoc &amp; to External Sites</a>
</li><li><a href="/index.php/Help:Lists" title="Help:Lists">How to Make Lists</a>
</li><li><a href="/index.php/Help:Ignoring_Formatting" title="Help:Ignoring Formatting">How to Ignoring Formatting</a>
</li><li><a href="/index.php/Help:Adding_References_to_Articles" title="Help:Adding References to Articles">Adding References or Footnotes to Articles</a>
</li><li><a href="/index.php/Help:Tracking_Changes" title="Help:Tracking Changes">Tracking Changes You Have Made</a>
</li><li><a href="/index.php/Help:Categories" title="Help:Categories">How to Put an Article Into a Category</a>
</li><li><a href="/index.php/Help:Redirection" title="Help:Redirection">When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection</a>
</li></ul>
</td><td style="background:#FFFFEE;padding:7px;width:50%" valign="top">
<p><b>Advanced editing</b>
</p>
<ul><li><a href="/index.php/Help:Tables" title="Help:Tables">How to Make Tables</a>
</li><li><a href="/index.php/Help:Images_and_other_Media" title="Help:Images and other Media">How to Insert Images and Other Media</a>
</li><li><a href="/index.php/Help:Adding_Video" class="mw-redirect" title="Help:Adding Video">How to Add Video</a>
</li><li><a href="/index.php/Help:How_to_Make_Columns" title="Help:How to Make Columns">Help:How to Make Columns</a>
</li><li><a href="/index.php/Web_colors" title="Web colors">Web Colors</a>
</li><li><a href="/index.php/Help:Templates" title="Help:Templates">How To Make Templates</a>
</li><li><a href="/index.php/Help:Moving_Pages" title="Help:Moving Pages">How to Move Pages</a>
</li><li><a href="/index.php/Help:Insert_Dates_and_Times" title="Help:Insert Dates and Times">Inserting Dynamic Dates and Times</a>
</li><li><a href="/index.php/Help:Inserting_Statistics" title="Help:Inserting Statistics">Inserting WikiDoc Statistics</a>
</li><li><a href="/index.php/Help:Editing_the_Table_of_Contents" title="Help:Editing the Table of Contents">Editing the Table of Contents</a>
</li></ul>
<p><b>Communicating your edits</b>
</p>
<ul><li><a href="/index.php/Help:Edit_summary" title="Help:Edit summary">Let others know what you changed: The importance of Edit Summaries</a>
</li><li><a href="/index.php/Help:Minor_Edits" title="Help:Minor Edits">Minor Edits</a>
</li><li><a href="/index.php/Help:Edit_Conflicts" title="Help:Edit Conflicts">Edit Conflicts</a>
</li></ul>
<p><b>Help Videos You Can Watch</b>
</p>
<ul><li><a href="/index.php/Getting_Started_Video" class="mw-redirect" title="Getting Started Video">Getting Started Video</a>
</li></ul>
</td></tr>
</table>
</td></tr></table>
<a name="Acknowledgement_and_Attribution_Regarding_Sources_of_Content"></a><h2> <span class="mw-headline">Acknowledgement and Attribution Regarding Sources of Content</span></h2>
<p><small>Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as <a href="http://www.wikipedia.org" class="external text" title="http://www.wikipedia.org" rel="nofollow">Wikipedia</a> and <a href="http://www.askdrwiki.com" class="external text" title="http://www.askdrwiki.com" rel="nofollow">AskDrWiki</a>. Drug information for patients came from the <a href="http://www.nlm.nih.gov/" class="external text" title="http://www.nlm.nih.gov/" rel="nofollow">The National Library of Medicine</a>. Infectious disease information may have come from the Centers for Disease Control <a href="http://www.cdc.gov/" class="external text" title="http://www.cdc.gov/" rel="nofollow">(CDC)</a>. Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.<a href="http://www.diseasesdatabase.com/index.asp" class="external text" title="http://www.diseasesdatabase.com/index.asp" rel="nofollow">The Disease Database</a>; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne.  Differential Diagnosis Pocket.  Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 . </small></div><div class="printfooter">
Retrieved from "<a href="http://www.wikidoc.org/index.php/Pseudoephedrine">http://www.wikidoc.org/index.php/Pseudoephedrine</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/index.php/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/index.php/Category:Amphetamines" title="Category:Amphetamines">Amphetamines</a></span> | <span dir='ltr'><a href="/index.php/Category:Amphetamine_alkaloids" title="Category:Amphetamine alkaloids">Amphetamine alkaloids</a></span> | <span dir='ltr'><a href="/index.php/Category:Decongestants" title="Category:Decongestants">Decongestants</a></span> | <span dir='ltr'><a href="/index.php/Category:Sympathomimetic_amines" title="Category:Sympathomimetic amines">Sympathomimetic amines</a></span> | <span dir='ltr'><a href="/index.php/Category:DEA_List_I_chemicals" title="Category:DEA List I chemicals">DEA List I chemicals</a></span></div></div>			<!-- end content -->
			<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/index.php/Pseudoephedrine" title="View the content page [c]" accesskey="c">Page</a></li>
				 <li id="ca-talk" class="new"><a href="/index.php?title=Talk:Pseudoephedrine&amp;action=edit" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-viewsource"><a href="/index.php?title=Pseudoephedrine&amp;action=edit" title="This page is protected.&#10;You can view its source. [e]" accesskey="e">View source</a></li>
				 <li id="ca-history"><a href="/index.php?title=Pseudoephedrine&amp;action=history" title="Past versions of this page. [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/index.php?title=Special:UserLogin&amp;returnto=Pseudoephedrine" title="You are encouraged to log in, it is not mandatory however. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(/mediumwikidoc.jpg);" href="/index.php/Main_Page" title="Visit the Main Page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/index.php/Special:Search" id="searchform"><div>
				<input id="searchInput" name="search" type="text" title="Search wikidoc [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search the pages for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-WikiDoc"><a href="/index.php/Main_Page">WikiDoc</a></li>
				<li id="n-WikiPatient"><a href="/index.php/WikiPatient">WikiPatient</a></li>
				<li id="n-Become-an-Editor"><a href="/index.php/Editor_Application">Become an Editor</a></li>
				<li id="n-Recent-Changes"><a href="/index.php/Special:RecentChanges">Recent Changes</a></li>
				<li id="n-Table-of-Contents"><a href="/index.php/Special:AllPages">Table of Contents</a></li>
				<li id="n-Suggestions"><a href="/index.php/Suggestions">Suggestions</a></li>
			</ul>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-help'>

		<h5>Help</h5>
		<span id="toctestx" class="toctest">
		[<a id="togglelinkx" class="internal" href="javascript:toggletestToc('toctestx','div','togglelinkx')"> + </a>]
		<div class='pBody' style="display:none">
			<ul>
				<li id="n-What-is-a-wiki.3F"><a href="/index.php/What_is_a_wiki">What is a wiki?</a></li>
				<li id="n-Help-Menu"><a href="/index.php/Help_Menu">Help Menu</a></li>
				<li id="n-Create-a-Page"><a href="/index.php/Firstpage">Create a Page</a></li>
				<li id="n-Edit-a-Page"><a href="/index.php/Help:Editing">Edit a Page</a></li>
				<li id="n-Insert-a-Reference"><a href="/index.php/Citations">Insert a Reference</a></li>
				<li id="n-Insert-a-Video"><a href="/index.php/Help:Videos">Insert a Video</a></li>
				<li id="n-Insert-an-Image"><a href="/index.php/Images">Insert an Image</a></li>
				<li id="n-Insert-a-Table"><a href="/index.php/Help:Tables">Insert a Table</a></li>
				<li id="n-Insert-a-Link"><a href="/index.php/Linking">Insert a Link</a></li>
				<li id="n-Policies"><a href="/index.php/Policies">Policies</a></li>
				<li id="n-FAQ.27s"><a href="/index.php/FAQ%27s">FAQ's</a></li>
			</ul>
		</div>
	</span>
	</div>
			<div class="portlet"> 
	<h5>related articles</h5> 	
	<div class="pBody">	
			  
		
		<div id="toctest1" class="toctest">	
		<div id="spec"  style="height: 3px;">
		</div>
		viewed previously [<a id="togglelink1" class="internal" href="javascript:toggletestToc('toctest1','ul','togglelink1')"> + </a>]
		<ul style="display:none;">	<li><a  href="../index.php/Phenylephrine">Phenylephrine (patient<br>information)&nbsp;(21)</a></li><li><a  href="../index.php/Vasoconstrictor">Vasoconstrictor&nbsp;(9)</a></li><li><a  href="../index.php/Ephedrine">Ephedrine&nbsp;(9)</a></li><li><a  href="../index.php/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons">Standard for the Uniform<br>Scheduling of D&nbsp;(6)</a></li><li><a  href="../index.php/Phenylpropanolamine">Phenylpropanolamine&nbsp;(6)</a></li> 	</ul>
		</div>
	<hr/>		<div id="toctest2" class="toctest">
		often viewed next [<a id="togglelink2" class="internal" href="javascript:toggletestToc('toctest2','ul','togglelink2')"> + </a>]
		<ul style="display:none;"> <li><a href="../index.php/Phenylephrine">Phenylephrine (patient<br>information)&nbsp;(16)</a></li><li><a href="../index.php/Ephedrine">Ephedrine&nbsp;(9)</a></li><li><a href="../index.php/Hypertension">Hypertension&nbsp;(8)</a></li><li><a href="../index.php/Methamphetamine">Methamphetamine&nbsp;(6)</a></li> </ul>
		</div>		  
	 
	</div></div>
		<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/index.php/Special:WhatLinksHere/Pseudoephedrine" title="List of all wiki pages that link here [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/index.php/Special:RecentChangesLinked/Pseudoephedrine" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/index.php/Special:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/index.php/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/index.php?title=Pseudoephedrine&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/index.php?title=Pseudoephedrine&amp;oldid=470181" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-contributors"><a href="/index.php?title=Special:Contributors&amp;target=Pseudoephedrine">Main contributors</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>In other languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-es"><a href="http://es.wikidoc.org/index.php/Pseudoefedrina">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikidoc.org/index.php/Pseudo%C3%A9ph%C3%A9drine">Français</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikidoc.org/index.php/%E5%A1%A9%E9%85%B8%E3%83%97%E3%82%BD%E3%82%A4%E3%83%89%E3%82%A8%E3%83%95%E3%82%A7%E3%83%89%E3%83%AA%E3%83%B3">日本語</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikidoc.org/index.php/Pseudoefedryna">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikidoc.org/index.php/Pseudoefedrina">Português</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://creativecommons.org/licenses/by-sa/3.0/"><img src="http://i.creativecommons.org/l/by-sa/3.0/80x15.png" alt='Creative Commons Attribution/Share-Alike License' /></a></div>
			<ul id="f-list">
				<li id="credits">This page was last modified 23:33, 30 July 2008 by <a href="/index.php/User:Zorkun" title="User:Zorkun">Cafer Zorkun</a>. Based on work by <a href="/index.php/User:Alara" title="User:Alara">Alara Eren</a>, <a href="/index.php?title=User:Alexandra_Almonacid_E.&amp;action=edit&amp;redlink=1" class="new" title="User:Alexandra Almonacid E. (not yet written)">Alexandra Almonacid</a> and <a href="/index.php?title=User:Pilar_Almonacid&amp;action=edit&amp;redlink=1" class="new" title="User:Pilar Almonacid (not yet written)">Pilar Almonacid</a> and Anonymous user(s) of wikidoc.</li>
				<li id="copyright">Content is available under <a href="http://creativecommons.org/licenses/by-sa/3.0/" class="external " title="http://creativecommons.org/licenses/by-sa/3.0/" rel="nofollow">Creative Commons Attribution/Share-Alike License</a>.</li>
				<li id="privacy"><a href="/index.php/wikidoc:Privacy_policy" title="wikidoc:Privacy policy">Privacy policy</a></li>
				<li id="about"><a href="/index.php/wikidoc:About" title="wikidoc:About">About wikidoc</a></li>
				<li id="disclaimer"><a href="/index.php/wikidoc:General_disclaimer" title="wikidoc:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
var pageTracker = _gat._getTracker("UA-1331958-2");
pageTracker._initData();
pageTracker._trackPageview();
</script><!-- Served in 0.460 secs. --></body></html>
